| positive regulation of mrna 3 end processing | GO:0031442 | 12 | 1.000 | Human |
| regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:1900151 | 8 | 0.998 | Human |
| regulation of nuclear transcribed mrna poly a tail shortening | GO:0060211 | 8 | 0.991 | Human |
| positive regulation of mrna catabolic process | GO:0061014 | 10 | 0.983 | Human |
| positive regulation of mrna processing | GO:0050685 | 17 | 0.976 | Human |
| nuclear transcribed mrna catabolic process exonucleolytic | GO:0000291 | 7 | 0.945 | |
| regulation of mrna 3 end processing | GO:0031440 | 12 | 0.938 | Human |
| regulation of mrna catabolic process | GO:0061013 | 13 | 0.935 | Human |
| positive regulation of meiotic cell cycle | GO:0051446 | 2 | 0.930 | |
| positive regulation of mrna metabolic process | GO:1903313 | 19 | 0.927 | Human |
| rna phosphodiester bond hydrolysis exonucleolytic | GO:0090503 | 14 | 0.889 | |
| mrna catabolic process | GO:0006402 | 56 | 0.879 | Human |
| mrna 3 end processing | GO:0031124 | 24 | 0.848 | Human |
| rna catabolic process | GO:0006401 | 71 | 0.840 | Human |
| positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:1900153 | 8 | 0.814 | Human |
| nuclear transcribed mrna catabolic process | GO:0000956 | 48 | 0.732 | Human |
| nuclear transcribed mrna poly a tail shortening | GO:0000289 | 8 | 0.702 | Human |
| nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:0000288 | 14 | 0.681 | Human |
| positive regulation of nuclear transcribed mrna poly a tail shortening | GO:0060213 | 8 | 0.639 | Human |
| rna 3 end processing | GO:0031123 | 35 | 0.631 | Human |
| regulation of stem cell differentiation | GO:2000736 | 56 | 0.631 | |
| g2 dna damage checkpoint | GO:0031572 | 26 | 0.599 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.538 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.506 | Human |
| regulation of meiotic cell cycle | GO:0051445 | 4 | 0.487 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.486 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.436 | Human |
| mitotic cell cycle process | GO:1903047 | 286 | 0.426 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.414 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.404 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.395 | Human |
| post embryonic development | GO:0009791 | 2 | 0.392 | |
| rna phosphodiester bond hydrolysis | GO:0090501 | 35 | 0.326 | |
| mrna metabolic process | GO:0016071 | 175 | 0.325 | Human |
| translation | GO:0006412 | 132 | 0.321 | Human |
| cell development | GO:0048468 | 328 | 0.316 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.316 | Human |
| amine metabolic process | GO:0009308 | 44 | 0.297 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.297 | Human |
| exonucleolytic nuclear transcribed mrna catabolic process involved in deadenylation dependent decay | GO:0043928 | 6 | 0.292 | |
| rna processing | GO:0006396 | 255 | 0.278 | Human |
| determination of adult lifespan | GO:0008340 | 2 | 0.253 | |
| positive regulation of cell cycle | GO:0045787 | 140 | 0.221 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.220 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.219 | Human |
| positive regulation of fibroblast apoptotic process | GO:2000271 | 6 | 0.217 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 102 | 0.213 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.210 | |
| regulation of mrna metabolic process | GO:1903311 | 53 | 0.205 | Human |
| mrna processing | GO:0006397 | 133 | 0.204 | Human |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.201 | Human |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.200 | |
| regulation of mrna processing | GO:0050684 | 48 | 0.199 | Human |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 118 | 0.182 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.181 | |
| cytoplasmic mrna processing body assembly | GO:0033962 | 10 | 0.179 | |
| negative regulation of dna metabolic process | GO:0051053 | 57 | 0.170 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 85 | 0.170 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.166 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.162 | |
| neurogenesis | GO:0022008 | 169 | 0.153 | Human |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.153 | |
| generation of neurons | GO:0048699 | 152 | 0.146 | Human |
| cell cycle checkpoint | GO:0000075 | 117 | 0.140 | |
| cell type specific apoptotic process | GO:0097285 | 125 | 0.139 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.134 | Human |
| negative regulation of cell cycle phase transition | GO:1901988 | 89 | 0.127 | |
| hemopoiesis | GO:0030097 | 180 | 0.125 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.125 | |
| cardiovascular system development | GO:0072358 | 262 | 0.124 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.119 | Human |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.114 | |
| blood vessel development | GO:0001568 | 172 | 0.113 | |
| regulation of translation | GO:0006417 | 89 | 0.112 | Human |
| mitotic dna integrity checkpoint | GO:0044774 | 30 | 0.110 | |
| regulation of stem cell maintenance | GO:2000036 | 4 | 0.110 | |
| cranial nerve morphogenesis | GO:0021602 | 1 | 0.109 | |
| system process | GO:0003008 | 349 | 0.107 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.104 | |
| neuron differentiation | GO:0030182 | 138 | 0.104 | Human |
| protein ubiquitination | GO:0016567 | 314 | 0.103 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.102 | |
| dna damage checkpoint | GO:0000077 | 68 | 0.100 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.099 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.098 | |
| response to hormone | GO:0009725 | 175 | 0.098 | Rat |
| organelle assembly | GO:0070925 | 176 | 0.097 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.097 | |
| mitotic cell cycle checkpoint | GO:0007093 | 68 | 0.095 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.094 | |
| regulation of cytoplasmic mrna processing body assembly | GO:0010603 | 5 | 0.093 | |
| immune system development | GO:0002520 | 195 | 0.088 | |
| mitotic dna damage checkpoint | GO:0044773 | 28 | 0.086 | |
| growth | GO:0040007 | 202 | 0.083 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.083 | |
| dna integrity checkpoint | GO:0031570 | 71 | 0.082 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.082 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.076 | |
| fibroblast apoptotic process | GO:0044346 | 8 | 0.076 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.075 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.074 | |
| regulation of cytokine production | GO:0001817 | 232 | 0.073 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.072 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.071 | |
| epithelium development | GO:0060429 | 227 | 0.071 | |
| nervous system development | GO:0007399 | 293 | 0.070 | Human |
| regulation of cellular component movement | GO:0051270 | 334 | 0.069 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.069 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.068 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.068 | |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.068 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 127 | 0.065 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.062 | |
| muscle organ development | GO:0007517 | 56 | 0.062 | |
| positive regulation of cytoplasmic mrna processing body assembly | GO:0010606 | 4 | 0.061 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.061 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.059 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.059 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 78 | 0.058 | |
| stem cell development | GO:0048864 | 69 | 0.056 | |
| ribonucleoprotein complex assembly | GO:0022618 | 78 | 0.056 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 4 | 0.055 | |
| somatic stem cell maintenance | GO:0035019 | 4 | 0.054 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.054 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.054 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.054 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.053 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.052 | |
| tissue regeneration | GO:0042246 | 3 | 0.049 | |
| lymphocyte activation | GO:0046649 | 133 | 0.049 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 42 | 0.049 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.048 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.048 | |
| negative regulation of immune system process | GO:0002683 | 136 | 0.047 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.047 | |
| cell growth | GO:0016049 | 160 | 0.047 | |
| angiogenesis | GO:0001525 | 147 | 0.047 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 207 | 0.047 | |
| gene silencing | GO:0016458 | 49 | 0.047 | |
| negative regulation of endopeptidase activity | GO:0010951 | 84 | 0.047 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.046 | |
| regulation of muscle cell differentiation | GO:0051147 | 31 | 0.045 | |
| associative learning | GO:0008306 | 1 | 0.045 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.045 | |
| protein localization to organelle | GO:0033365 | 280 | 0.045 | |
| regulation of vasculature development | GO:1901342 | 97 | 0.045 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.044 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.044 | Rat |
| peptidyl lysine modification | GO:0018205 | 144 | 0.043 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.043 | |
| negative regulation of translation | GO:0017148 | 37 | 0.043 | Human |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.043 | Human |
| cellular response to oxidative stress | GO:0034599 | 85 | 0.043 | |
| positive regulation of myoblast differentiation | GO:0045663 | 6 | 0.043 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.043 | Rat |
| lipid metabolic process | GO:0006629 | 381 | 0.042 | |
| response to oxidative stress | GO:0006979 | 121 | 0.042 | Rat |
| protein processing | GO:0016485 | 226 | 0.042 | |
| regulation of heart contraction | GO:0008016 | 50 | 0.042 | |
| ribonucleoprotein complex subunit organization | GO:0071826 | 81 | 0.041 | |
| positive regulation of transport | GO:0051050 | 336 | 0.041 | |
| vasculature development | GO:0001944 | 181 | 0.041 | |
| immune response | GO:0006955 | 307 | 0.040 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.040 | |
| regulation of growth | GO:0040008 | 165 | 0.040 | |
| regulation of angiogenesis | GO:0045765 | 92 | 0.040 | |
| nuclear transcribed mrna catabolic process nonsense mediated decay | GO:0000184 | 23 | 0.040 | |
| single organism cellular localization | GO:1902580 | 332 | 0.039 | |
| regulation of protein localization | GO:0032880 | 296 | 0.039 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.039 | |
| protein maturation | GO:0051604 | 233 | 0.039 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.039 | |
| myeloid cell differentiation | GO:0030099 | 117 | 0.038 | |
| response to hypoxia | GO:0001666 | 96 | 0.038 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.038 | |
| regulation of protein maturation | GO:1903317 | 150 | 0.038 | |
| gtp metabolic process | GO:0046039 | 239 | 0.037 | |
| regulation of cell migration | GO:0030334 | 289 | 0.037 | |
| regulation of muscle tissue development | GO:1901861 | 26 | 0.037 | |
| regulation of cytoskeleton organization | GO:0051493 | 177 | 0.037 | |
| negative regulation of protein maturation | GO:1903318 | 142 | 0.037 | |
| metal ion transport | GO:0030001 | 272 | 0.036 | |
| defense response | GO:0006952 | 315 | 0.036 | |
| neuron development | GO:0048666 | 113 | 0.036 | Human |
| nuclear transcribed mrna catabolic process no go decay | GO:0070966 | 2 | 0.035 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.035 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.035 | |
| female gamete generation | GO:0007292 | 2 | 0.035 | |
| limbic system development | GO:0021761 | 3 | 0.035 | |
| rho protein signal transduction | GO:0007266 | 26 | 0.035 | |
| cytokine production | GO:0001816 | 247 | 0.034 | |
| cation transport | GO:0006812 | 331 | 0.034 | |
| regulation of protein ubiquitination | GO:0031396 | 95 | 0.034 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.034 | |
| purine containing compound biosynthetic process | GO:0072522 | 88 | 0.034 | |
| cellular response to glucocorticoid stimulus | GO:0071385 | 4 | 0.033 | |
| regulation of system process | GO:0044057 | 101 | 0.033 | |
| leukocyte activation | GO:0045321 | 164 | 0.033 | |
| circulatory system development | GO:0072359 | 262 | 0.032 | |
| regulation of endothelial cell differentiation | GO:0045601 | 4 | 0.032 | |
| single organism reproductive process | GO:0044702 | 98 | 0.032 | Rat |
| response to organonitrogen compound | GO:0010243 | 156 | 0.032 | Rat |
| regulation of gtpase activity | GO:0043087 | 180 | 0.032 | |
| monocarboxylic acid metabolic process | GO:0032787 | 185 | 0.032 | |
| regulation of protein transport | GO:0051223 | 213 | 0.031 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.031 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.031 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.030 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.030 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.030 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 72 | 0.029 | |
| regulation of leukocyte proliferation | GO:0070663 | 67 | 0.029 | |
| negative regulation of protein processing | GO:0010955 | 142 | 0.029 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.029 | |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.028 | |
| regulation of cell growth | GO:0001558 | 135 | 0.028 | |
| mitotic g2 dna damage checkpoint | GO:0007095 | 7 | 0.028 | |
| negative regulation of organelle organization | GO:0010639 | 126 | 0.027 | |
| response to light stimulus | GO:0009416 | 87 | 0.027 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.027 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.027 | Human |
| regulation of ion transport | GO:0043269 | 189 | 0.027 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.027 | |
| regulation of neuron apoptotic process | GO:0043523 | 35 | 0.027 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.027 | |
| regulation of leukocyte differentiation | GO:1902105 | 61 | 0.026 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.026 | |
| locomotory behavior | GO:0007626 | 1 | 0.026 | |
| regulation of epithelial cell migration | GO:0010632 | 93 | 0.026 | |
| embryo development | GO:0009790 | 123 | 0.026 | |
| neuron apoptotic process | GO:0051402 | 39 | 0.026 | |
| response to nutrient levels | GO:0031667 | 81 | 0.026 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.026 | |
| mitotic g2 m transition checkpoint | GO:0044818 | 9 | 0.026 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.026 | |
| protein catabolic process | GO:0030163 | 325 | 0.026 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.026 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.025 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.025 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.025 | |
| biological adhesion | GO:0022610 | 331 | 0.025 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 40 | 0.025 | |
| muscle structure development | GO:0061061 | 98 | 0.025 | |
| negative regulation of proteolysis | GO:0045861 | 132 | 0.025 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.025 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.025 | |
| blastocyst development | GO:0001824 | 3 | 0.025 | |
| cell cycle g1 s phase transition | GO:0044843 | 80 | 0.025 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.024 | |
| actin filament based process | GO:0030029 | 224 | 0.024 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.024 | |
| response to starvation | GO:0042594 | 59 | 0.024 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.024 | |
| lymphocyte proliferation | GO:0046651 | 70 | 0.024 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.024 | |
| regulation of myeloid cell differentiation | GO:0045637 | 81 | 0.024 | |
| regeneration | GO:0031099 | 4 | 0.024 | |
| intracellular receptor signaling pathway | GO:0030522 | 104 | 0.024 | |
| cellular response to lipid | GO:0071396 | 127 | 0.023 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.023 | |
| tissue migration | GO:0090130 | 119 | 0.023 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.023 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.023 | |
| regulation of immune response | GO:0050776 | 201 | 0.023 | |
| sex differentiation | GO:0007548 | 45 | 0.023 | |
| mapk cascade | GO:0000165 | 288 | 0.023 | |
| reproductive system development | GO:0061458 | 56 | 0.023 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.023 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.022 | |
| nucleotide biosynthetic process | GO:0009165 | 109 | 0.022 | |
| regulation of striated muscle tissue development | GO:0016202 | 26 | 0.022 | |
| negative regulation of neural precursor cell proliferation | GO:2000178 | 1 | 0.022 | |
| positive regulation of ion transport | GO:0043270 | 87 | 0.022 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 200 | 0.022 | |
| activation of immune response | GO:0002253 | 114 | 0.022 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.022 | |
| nuclear transport | GO:0051169 | 179 | 0.022 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.022 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.021 | |
| blood circulation | GO:0008015 | 113 | 0.021 | |
| response to peptide | GO:1901652 | 65 | 0.021 | Rat |
| circulatory system process | GO:0003013 | 113 | 0.021 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.021 | |
| carboxylic acid biosynthetic process | GO:0046394 | 97 | 0.021 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.021 | |
| regulation of locomotion | GO:0040012 | 329 | 0.021 | |
| camp biosynthetic process | GO:0006171 | 47 | 0.021 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.021 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.021 | |
| reproduction | GO:0000003 | 63 | 0.021 | Rat |
| epithelial cell migration | GO:0010631 | 119 | 0.021 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 186 | 0.021 | |
| regulation of secretion | GO:0051046 | 194 | 0.021 | |
| segmentation | GO:0035282 | 4 | 0.021 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 2 | 0.021 | |
| t cell differentiation | GO:0030217 | 29 | 0.021 | |
| response to oxygen levels | GO:0070482 | 100 | 0.021 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.020 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 109 | 0.020 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 48 | 0.020 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.020 | |
| t cell activation | GO:0042110 | 99 | 0.020 | |
| response to metal ion | GO:0010038 | 84 | 0.020 | |
| regulation of ras gtpase activity | GO:0032318 | 128 | 0.020 | |
| peptidyl serine modification | GO:0018209 | 106 | 0.020 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 18 | 0.020 | |
| response to lipid | GO:0033993 | 206 | 0.020 | |
| adult locomotory behavior | GO:0008344 | 1 | 0.020 | |
| skeletal system development | GO:0001501 | 79 | 0.020 | |
| regulation of gtp catabolic process | GO:0033124 | 180 | 0.020 | |
| regulation of cell adhesion | GO:0030155 | 166 | 0.020 | |
| t cell differentiation in thymus | GO:0033077 | 4 | 0.019 | |
| regulation of cell activation | GO:0050865 | 125 | 0.019 | |
| regulation of neuron death | GO:1901214 | 56 | 0.019 | |
| trophectodermal cell differentiation | GO:0001829 | 3 | 0.019 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.019 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.019 | |
| response to virus | GO:0009615 | 126 | 0.019 | |
| response to extracellular stimulus | GO:0009991 | 85 | 0.019 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.019 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.019 | |
| regulation of heart growth | GO:0060420 | 4 | 0.019 | |
| regulation of actin filament based process | GO:0032970 | 141 | 0.019 | |
| regulation of fibroblast apoptotic process | GO:2000269 | 8 | 0.019 | |
| negative regulation of chromosome organization | GO:2001251 | 48 | 0.019 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 205 | 0.019 | |
| cranial nerve formation | GO:0021603 | 1 | 0.019 | |
| regulation of chromosome organization | GO:0033044 | 103 | 0.019 | |
| regulation of lymphocyte proliferation | GO:0050670 | 64 | 0.019 | |
| intracellular protein transport | GO:0006886 | 270 | 0.019 | |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.019 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 54 | 0.018 | |
| ventral spinal cord development | GO:0021517 | 1 | 0.018 | |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.018 | |
| mitochondrial transport | GO:0006839 | 60 | 0.018 | |
| oogenesis | GO:0048477 | 2 | 0.018 | |
| positive regulation of muscle cell differentiation | GO:0051149 | 15 | 0.018 | |
| negative regulation of homeostatic process | GO:0032845 | 59 | 0.018 | |
| endocytosis | GO:0006897 | 159 | 0.018 | |
| regulation of homeostatic process | GO:0032844 | 121 | 0.018 | |
| cell activation | GO:0001775 | 213 | 0.018 | |
| negative regulation of gliogenesis | GO:0014014 | 3 | 0.018 | |
| muscle system process | GO:0003012 | 81 | 0.018 | |
| regulation of lymphocyte activation | GO:0051249 | 103 | 0.018 | |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.018 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.018 | |
| reproductive process | GO:0022414 | 106 | 0.018 | Rat |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.018 | Human |
| cellular response to nutrient levels | GO:0031669 | 69 | 0.018 | |
| organ formation | GO:0048645 | 3 | 0.018 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.017 | |
| negative regulation of retinoic acid receptor signaling pathway | GO:0048387 | 4 | 0.017 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 23 | 0.017 | |
| regulation of membrane potential | GO:0042391 | 95 | 0.017 | |
| leukocyte proliferation | GO:0070661 | 74 | 0.017 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.017 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.017 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.017 | |
| deadenylation dependent decapping of nuclear transcribed mrna | GO:0000290 | 1 | 0.017 | |
| urogenital system development | GO:0001655 | 65 | 0.017 | |
| response to decreased oxygen levels | GO:0036293 | 96 | 0.017 | |
| erythrocyte differentiation | GO:0030218 | 28 | 0.017 | |
| dna replication | GO:0006260 | 116 | 0.017 | |
| positive regulation of gtpase activity | GO:0043547 | 166 | 0.017 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 89 | 0.016 | |
| regulation of mesonephros development | GO:0061217 | 3 | 0.016 | |
| cardiac muscle contraction | GO:0060048 | 34 | 0.016 | |
| regulation of myotube differentiation | GO:0010830 | 18 | 0.016 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.016 | |
| protein methylation | GO:0006479 | 74 | 0.016 | Mouse |
| regulation of cell development | GO:0060284 | 161 | 0.016 | |
| striated muscle contraction | GO:0006941 | 52 | 0.016 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 70 | 0.016 | |
| regulation of leukocyte activation | GO:0002694 | 115 | 0.016 | |
| negative regulation of cell motility | GO:2000146 | 104 | 0.016 | |
| positive regulation of cell cycle process | GO:0090068 | 106 | 0.016 | |
| receptor mediated endocytosis | GO:0006898 | 84 | 0.016 | |
| positive regulation of gtp catabolic process | GO:0033126 | 166 | 0.016 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.016 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 65 | 0.016 | |
| muscle tissue development | GO:0060537 | 62 | 0.016 | |
| negative regulation of nf kappab transcription factor activity | GO:0032088 | 51 | 0.016 | |
| signal transduction by p53 class mediator | GO:0072331 | 72 | 0.016 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.016 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.016 | |
| cell morphogenesis | GO:0000902 | 296 | 0.016 | |
| positive regulation of organelle assembly | GO:1902117 | 17 | 0.016 | |
| histone modification | GO:0016570 | 251 | 0.016 | |
| regulation of immune effector process | GO:0002697 | 91 | 0.015 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.015 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.015 | |
| regulation of glial cell differentiation | GO:0045685 | 3 | 0.015 | |
| negative regulation of catabolic process | GO:0009895 | 104 | 0.015 | |
| ventricular septum morphogenesis | GO:0060412 | 3 | 0.015 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.015 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.015 | |
| regulation of neurogenesis | GO:0050767 | 82 | 0.015 | |
| reproductive structure development | GO:0048608 | 55 | 0.015 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.015 | |
| response to mechanical stimulus | GO:0009612 | 51 | 0.015 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 0.015 | |
| establishment of protein localization to organelle | GO:0072594 | 172 | 0.015 | |
| small molecule biosynthetic process | GO:0044283 | 157 | 0.015 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 4 | 0.015 | |
| regulation of ligand dependent nuclear receptor transcription coactivator activity | GO:2000325 | 3 | 0.015 | |
| guanosine containing compound catabolic process | GO:1901069 | 239 | 0.015 | |
| negative regulation of erythrocyte differentiation | GO:0045647 | 3 | 0.014 | |
| regulation of b cell activation | GO:0050864 | 24 | 0.014 | |
| positive regulation of immune response | GO:0050778 | 159 | 0.014 | |
| macromolecule methylation | GO:0043414 | 97 | 0.014 | Mouse |
| generation of precursor metabolites and energy | GO:0006091 | 68 | 0.014 | |
| protein acetylation | GO:0006473 | 116 | 0.014 | |
| pattern specification process | GO:0007389 | 43 | 0.014 | |
| regulation of protein processing | GO:0070613 | 150 | 0.014 | |
| positive regulation of epithelial cell migration | GO:0010634 | 55 | 0.014 | |
| negative regulation of peptidase activity | GO:0010466 | 91 | 0.014 | |
| organ morphogenesis | GO:0009887 | 147 | 0.014 | |
| positive regulation of binding | GO:0051099 | 45 | 0.014 | |
| innate immune response | GO:0045087 | 178 | 0.014 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.014 | |
| peripheral nervous system development | GO:0007422 | 2 | 0.014 | |
| stem cell maintenance | GO:0019827 | 19 | 0.014 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.014 | |
| regulation of ras protein signal transduction | GO:0046578 | 155 | 0.014 | |
| modification dependent protein catabolic process | GO:0019941 | 209 | 0.014 | |
| heart process | GO:0003015 | 62 | 0.014 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.014 | |
| leukocyte differentiation | GO:0002521 | 98 | 0.014 | |
| homeostasis of number of cells | GO:0048872 | 40 | 0.014 | |
| regulation of transcription elongation from rna polymerase ii promoter | GO:0034243 | 13 | 0.013 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 3 | 0.013 | |
| methylation | GO:0032259 | 106 | 0.013 | Mouse |
| regulation of myoblast differentiation | GO:0045661 | 12 | 0.013 | |
| regulation of growth rate | GO:0040009 | 1 | 0.013 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.013 | |
| sulfur compound biosynthetic process | GO:0044272 | 38 | 0.013 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 43 | 0.013 | |
| positive regulation of i kappab kinase nf kappab signaling | GO:0043123 | 132 | 0.013 | |
| microtubule cytoskeleton organization | GO:0000226 | 176 | 0.013 | |
| cellular response to starvation | GO:0009267 | 58 | 0.013 | |
| regulation of protein secretion | GO:0050708 | 86 | 0.013 | |
| positive regulation of camp biosynthetic process | GO:0030819 | 35 | 0.013 | |
| cdc42 protein signal transduction | GO:0032488 | 4 | 0.013 | |
| spinal cord development | GO:0021510 | 4 | 0.013 | |
| multicellular organism reproduction | GO:0032504 | 42 | 0.013 | Rat |
| muscle contraction | GO:0006936 | 73 | 0.013 | |
| positive regulation of protein transport | GO:0051222 | 135 | 0.013 | |
| positive regulation of protein catabolic process | GO:0045732 | 75 | 0.013 | |
| negative regulation of neuron death | GO:1901215 | 32 | 0.013 | |
| epithelium migration | GO:0090132 | 119 | 0.013 | |
| meiosis i | GO:0007127 | 4 | 0.013 | |
| oxidation reduction process | GO:0055114 | 396 | 0.013 | |
| organic acid biosynthetic process | GO:0016053 | 97 | 0.013 | |
| neuron death | GO:0070997 | 65 | 0.013 | |
| peptide transport | GO:0015833 | 74 | 0.013 | |
| negative regulation of growth | GO:0045926 | 97 | 0.013 | |
| mrna destabilization | GO:0061157 | 1 | 0.012 | |
| negative regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043154 | 46 | 0.012 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 41 | 0.012 | |
| regulation of dna replication | GO:0006275 | 68 | 0.012 | |
| secretion | GO:0046903 | 254 | 0.012 | |
| regulation of protein catabolic process | GO:0042176 | 155 | 0.012 | |
| peptidyl lysine acetylation | GO:0018394 | 101 | 0.012 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.012 | |
| cation homeostasis | GO:0055080 | 189 | 0.012 | |
| ameboidal type cell migration | GO:0001667 | 135 | 0.012 | |
| b cell activation | GO:0042113 | 33 | 0.012 | |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 162 | 0.012 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 107 | 0.012 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.012 | |
| rab protein signal transduction | GO:0032482 | 4 | 0.012 | |
| regulation of rho protein signal transduction | GO:0035023 | 79 | 0.012 | |
| positive regulation of mononuclear cell proliferation | GO:0032946 | 47 | 0.012 | |
| nucleus localization | GO:0051647 | 1 | 0.012 | |
| lymphocyte homeostasis | GO:0002260 | 4 | 0.012 | |
| immune effector process | GO:0002252 | 159 | 0.012 | |
| internal protein amino acid acetylation | GO:0006475 | 101 | 0.012 | |
| positive regulation of mesonephros development | GO:0061213 | 2 | 0.012 | |
| leukocyte mediated immunity | GO:0002443 | 59 | 0.012 | |
| cellular response to hypoxia | GO:0071456 | 51 | 0.012 | |
| camp metabolic process | GO:0046058 | 61 | 0.012 | |
| immune response activating signal transduction | GO:0002757 | 90 | 0.012 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 38 | 0.012 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.012 | |
| lens development in camera type eye | GO:0002088 | 2 | 0.012 | |
| cell cycle arrest | GO:0007050 | 71 | 0.012 | |
| regulation of cell motility | GO:2000145 | 299 | 0.012 | |
| photoreceptor cell differentiation | GO:0046530 | 2 | 0.012 | |
| motor neuron axon guidance | GO:0008045 | 2 | 0.012 | |
| response to wounding | GO:0009611 | 168 | 0.012 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 88 | 0.012 | |
| cell projection organization | GO:0030030 | 252 | 0.012 | Human |
